|
Delayed
Deutsche Boerse AG
03:47:20 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 9.650 EUR | -5.39% |
|
+2.66% | +54.40% |
| 08-12 | B. Riley Adjusts Fennec Pharmaceuticals Price Target to $18 From $16, Maintains Buy Rating | MT |
| 08-11 | Fennec Pharmaceuticals at Multi-Year High After Swing to Q2 Earnings Beat | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.43% | +4.31% | +2.67% | +23.28% | +13.55% | +90.84% | +130.99% | +363.16% | +1,421.17% | 1,088B | |
| +0.41% | +1.27% | +1.51% | +16.32% | +26.05% | +50.98% | +50.05% | +48.89% | +111.70% | 629B | |
| -0.53% | +1.04% | +0.27% | +19.68% | +8.87% | +25.23% | +63.46% | +115.12% | +270.23% | 440B | |
| -0.31% | -0.14% | +10.13% | +13.81% | +10.97% | +45.86% | +37.51% | -1.02% | +46.38% | 359B | |
| -0.24% | -1.02% | -0.55% | +6.08% | +13.05% | +27.05% | +36.27% | +44.14% | +54.30% | 291B | |
| -0.45% | -1.69% | -7.61% | -15.37% | -15.52% | +1.80% | +4.82% | +38.26% | +126.48% | 245B | |
| +0.45% | +2.05% | +14.53% | +23.76% | +27.15% | +46.04% | +58.54% | +82.42% | +140.54% | 225B | |
| -0.87% | +1.31% | -8.31% | -0.58% | -8.55% | -8.73% | -51.97% | -8.08% | +91.16% | 204B | |
| +0.07% | +3.12% | +4.65% | +0.69% | +10.70% | +13.21% | +69.84% | +91.69% | +70.56% | 168B | |
| -1.16% | +1.94% | +8.85% | +1.70% | +5.66% | +6.73% | -27.00% | -44.31% | -24.79% | 150B | |
| -0.74% | +8.44% | +8.31% | +17.27% | +15.96% | +35.58% | +50.27% | +169.87% | +417.81% | 133B | |
| +0.14% | +0.11% | +10.63% | +12.84% | +18.09% | +36.84% | +4.03% | -4.85% | +5.06% | 130B | |
| -0.11% | +1.37% | -2.30% | +3.59% | -8.93% | -9.44% | -22.83% | -13.86% | +4.93% | 104B | |
| -0.67% | -4.21% | -5.04% | -1.64% | +1.67% | +29.27% | +33.84% | -0.52% | -13.32% | 101B | |
| -0.13% | +6.08% | -0.76% | -8.07% | -12.96% | +14.71% | +68.59% | +74.66% | +506.34% | 74.22B | |
| -0.05% | +2.47% | +4.53% | +7.07% | +14.97% | +27.59% | +25.01% | +51.31% | +17.85% | 55.77B | |
| +0.55% | -2.35% | -3.37% | +27.05% | +30.34% | +80.00% | -8.48% | +0.94% | -51.09% | 54.43B | |
| -1.11% | +1.53% | -2.49% | -3.12% | -8.75% | -10.67% | +38.67% | -2.58% | +227.31% | 53.12B | |
| -0.49% | -3.26% | -1.78% | +8.70% | -4.35% | -0.14% | +6.24% | - | - | 42.82B | |
| Average | -0.25% | +1.94% | +1.78% | +8.06% | +7.26% | +26.46% | +29.89% | +55.85% | +190.15% | 239.39B | |
| Weighted average by Cap. | -0.06% | +2.12% | +2.38% | +12.85% | +11.11% | +43.19% | +55.83% | +122.67% | +435.04% |
- Stock Market
- Stocks
- FENC Stock
- RV41 Stock
- Sector Fennec Pharmaceuticals Inc.
Select your edition
All financial news and data tailored to specific country editions
